Ganli Pharmaceutical Co., Ltd.: application for listing license of Mendong Insulin injection is officially accepted by FDA of the United States.

[Ganli Pharmaceutical Industry: application for listing license of Mendong Insulin injection was formally accepted by FDA] Ganli Pharmaceutical announced that the company had previously submitted an application for permission for biological products of Mendong Insulin injection to the US Food and Drug Administration (referred to as "FDA"), and recently received a notice of formal acceptance from the FDA of the United States, entering the substantive review stage.